Research programme: viral vaccines - Variation Biotechnologies
Latest Information Update: 16 Jul 2016
At a glance
- Originator Variation Biotechnologies
- Developer Variation Biotechnologies; VBI Vaccines
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cytomegalovirus infections; Hepatitis A; Influenza virus infections; Measles; Shigella infections
- Discontinued Hepatitis B; Hepatitis C; HIV infections; Infections; Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hepatitis-A in Canada (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Influenza-virus-infections in Canada (IM)
- 16 Jul 2016 No recent reports of development identified for research development in Cytomegalovirus infections in Canada